Please assess the completion status of the following clinical trial:

Trial Title: Very Early Versus Delayed Angiography +/- Intervention on Outcomes in Patients With NSTEMI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* 18 years of age and over~* Patients presenting to hospitals with a clinical diagnosis of non-ST elevation myocardial infarction comprising:~  * Ischaemic symptoms (as defined in Appendix III of protocol)~ * Elevated high sensitivity Troponin T or I (above the normal range for individual hospitals)~* GRACE-2.0 score (www.gracescore.org) of either:~  * ≥118 (corresponding to 6-month death \>6%) OR~ * ≥90 but \<118 (corresponding to 6-month death \>3% but \<6%)~* If GRACE 2.0 score ≥90 or \<118 must have at least one additional high risk feature:~  * Anterior location of ECG changes (leads V2 - V5)~ * ST-segment depression in 2 contiguous leads (any territory) of 0.15mV/ 1.5mm.~ * Diabetes Mellitus on medication~ * High-sensitivity Troponin I or T 3 x ULN~* Onset of ischaemic symptoms at any time prior to admission but most recent episode within 12 hours to admission~* Intention to perform angiography and, if indicated, follow-on revascularisation~* Provision of assent or written consent~* Randomisation must be performed within 6 hours of admission~Exclusion Criteria~* ST elevation myocardial infarction~* Evident type 2 myocardial infarction (e.g. anaemia)~* Evidence of previous known cardiomyopathy~* Cardiogenic Shock~* Known severe valvular heart disease~* Need for urgent PCI according to ESC Guidelines (haemodynamic instability, VT, VF, recurrent or persistent pain)~* Any contraindication to PCI~* Current participation in another intervention trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A: Immediate angiography (Type: OTHER): Immediate angiography with follow-on revascularisation if indicated
- Group B: Standard of care angiography (Type: OTHER): Standard of care angiography with follow-on revascularisation if indicated (within 3-4 days, but will vary depending on recruiting centre)

Based on this trial design, predict the completion outcome and termination type (if applicable).